Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)
China · Delayed Price · Currency is CNY 13.09
-0.47 (-3.47%)
Jul 30, 2026, 3:04 PM CST
SHE:300519 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 260.58 | 265.36 | 267.66 | 270.4 | 351.49 | 320.88 |
Revenue Growth | 0.08% | -0.86% | -1.01% | -23.07% | 9.54% | 13.35% |
Gross Profit Gross Profit Growth | 108.04 | 102.22 | 89.77 | 110.37 | 181.68 | 175.58 |
Operating Income Operating Income Growth | 55.9 | 46.46 | 32.03 | 48.87 | 110.82 | 108.73 |
Net Income Net Income Growth | 56.04 | 54.21 | 50.39 | 64.36 | 108.82 | 114.28 |
Earnings Per Share EPS Growth | 0.35 | 0.34 | 0.31 | 0.40 | 0.68 | 0.71 |
EPS Growth | 9.54% | 9.68% | -22.50% | -41.18% | -4.23% | 14.52% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
The Radix Astragali Lives The Arteries to Drink The Radix Astragali Lives The Arteries to Drink Growth | 191.73 | 196.24 | 205.74 | 270.7 | 247.94 |
Shenjin Dan Capsule Shenjin Dan Capsule Growth | 22.54 | 23.45 | 22.93 | 26.9 | 28.18 |
American Ginseng Oral Liquid American Ginseng Oral Liquid Growth | 45.87 | 40.6 | 33.61 | 46.7 | 36.12 |
Other Products Other Products Growth | 4.98 | 7.26 | 8.01 | 7.07 | 8.53 |
Unallocated Other Business Unallocated Other Business Growth | 0.23 | 0.12 | 0.11 | 0.12 | 0.11 |
Total Total Growth | 265.36 | 267.66 | 270.4 | 351.49 | 320.88 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 771.53 | 711.84 | 688.42 | 698.95 | 737.03 | 718.67 |
Total Debt Total Debt Growth | - | - | - | - | - | - |
Net Cash (Debt) Net Cash Growth | 771.53 | 711.84 | 688.42 | 698.95 | 737.03 | 718.67 |
Net Cash Growth | 5.65% | 3.40% | -1.51% | -5.17% | 2.56% | 6.18% |
Net Cash Per Share Net Cash Per Share Growth | 4.83 | 4.46 | 4.24 | 4.34 | 4.61 | 4.46 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 78.9 | 68.92 | 53.43 | 53.29 | 126.43 | 142.36 |
Capital Expenditures CapEx Growth | -2.69 | -3.48 | -5.2 | -15.99 | -16.64 | -14.71 |
Free Cash Flow Free Cash Flow Growth | 76.21 | 65.45 | 48.23 | 37.3 | 109.78 | 127.64 |
Free Cash Flow Growth | 42.23% | 35.69% | 29.30% | -66.02% | -13.99% | 24.72% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 41.46% | 38.52% | 33.54% | 40.82% | 51.69% | 54.72% |
Operating Margin | 21.45% | 17.51% | 11.97% | 18.07% | 31.53% | 33.88% |
Pretax Margin | 25.23% | 23.90% | 21.30% | 27.06% | 35.73% | 41.12% |
Profit Margin | 21.50% | 20.43% | 18.83% | 23.80% | 30.96% | 35.62% |
FCF Margin | 29.25% | 24.66% | 18.02% | 13.80% | 31.23% | 39.78% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.300 | 0.300 | 0.400 | 0.500 | 0.600 |
Dividend Per Share Growth | 0% | 0% | -25.00% | -20.00% | -16.67% | 0% |
Dividend Yield | 2.21% | 2.06% | 2.36% | 2.60% | 3.54% | 3.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 37.31 | 43.98 | 42.14 | 41.20 | 23.03 | 28.27 |
P/FCF Ratio | 27.48 | 36.42 | 44.02 | 71.07 | 22.82 | 25.31 |
PS Ratio | 8.04 | 8.98 | 7.93 | 9.81 | 7.13 | 10.07 |